Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-09

FDA Approved: MOTEGRITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MOTEGRITY (prucalopride) from Takeda Pharmaceuticals America, Inc., updating its labeling related to the approved in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MOTEGRITY (Prucalopride)

Snippet

SUPPL AP for MOTEGRITY (PRUCALOPRIDE)